Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy-Reference-Cited by-同舟云学术

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy

Published:2010-10-20 Issue:10 Volume:5 Page:e13421
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Alkhalaf Alaa,Zürbig Petra,Bakker Stephan J. L.,Bilo Henk J. G.,Cerna Marie,Fischer Christine,Fuchs Sebastian,Janssen Bart,Medek Karel,Mischak Harald,Roob Johannes M.,Rossing Kasper,Rossing Peter,Rychlík Ivan,Sourij Harald,Tiran Beate,Winklhofer-Roob Brigitte M.,Navis Gerjan J.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Urinary proteomics in diabetes and CKD.;K Rossing;J Am Soc Nephrol,2008

2. Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus.;YM Smulders;J Lab Clin Med,1998

3. How heterogeneous is microalbuminuria in diabetes mellitus? The case for ‘benign’ and ‘malignant’ microalbuminuria.;CD Stehouwer;Nephrol Dial Transplant,1998

4. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.;AS Levey;Am J Kidney Dis,2009

5. Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease.;BA Julian;Proteomics Clin Appl,2009

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Proteomics and Machine Learning Methods to Study the Pathogenesis of Diabetic Nephropathy and Screen Urinary Biomarkers;Journal of Proteome Research;2024-07-01

2. Integration of Urinary Peptidome and Fecal Microbiome to Explore Patient Clustering in Chronic Kidney Disease;Proteomes;2024-04-01

3. Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios;Journal of Translational Medicine;2023-09-24

4. Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study;Pharmaceuticals;2023-09-14

5. Prognosis and personalizedin-silicoprediction of treatment efficacy in cardiovascular and chronic kidney disease: a proof-of-concept study;2023-08-06